- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mi | Cognition's phase 2 SHIMMER results finally allow dementia drug to shine | ||
| Di | BD, Babson Diagnostics expand fingertip blood draws to urgent care clinics, doctors' offices | ||
| Di | Dexcom taps generative AI lifestyle tips for its Stelo glucose sensor | ||
| Di | Sanofi, Teva look to 'next frontier' in IBD treatment after TL1A antibody hits mark in midstage trial | ||
| Di | Biomea's diabetes drug improves glucose control 3 months after FDA hold lifted | ||
| Di | Cash-strapped Portage finds hope in sale of lead asset, subsidiary to Immunova | ||
| Di | Fresh off $120M raise, AI-powered Terray is teaming up with Gilead in multi-pronged R&D pact | ||
| Di | Merck drops TIGIT asset and LAG-3 program, discontinuing several phase 3 trials | ||
| Mo | American Society of Hematology member surveys identify barriers to improving diversity in clinical trials | ||
| Mo | Boston Scientific recalls pacemakers at risk of triggering permanent safety mode | ||
| Mo | UCB's orchestra hits dud note: Novartis-partnered Parkinson's asset fails phase 2 | ||
| Mo | Roche mothballs another hemophilia A gene therapy under Spark amid plans to debut new hematologic asset | ||
| Mo | Candid Therapeutics unwraps three new collaborations to discover and develop T-cell engager antibodies | ||
| Mo | BMS keeps axing deals inked under old leadership, this time culling cell therapy pacts with Century, Immatics | ||
| Mo | Fluid Biomed raises $27M for its bioabsorbable brain aneurysm stent | ||
| Mo | Reviva's antipsychotic shows promise against schizophrenia symptoms in year-long study | ||
| Mo | FDA hits pause on another of PepGen's muscular dystrophy trials | ||
| Mo | Foghorn gives up on sole wholly owned clinical asset after phase 1 leukemia failure | ||
| Mo | Edgewise's skeletal myosin inhibitor reduces biomarker in phase 2 muscular dystrophy trial | ||
| Mo | PureTech's lung fibrosis drug slows decline in phase 2 trial | ||
| Mo | Pharming pays $66M for Abliva and its 'potential blockbuster' mitochondrial disease med | ||
| 13.12. | Incyte scraps anemia program after drug fails to improve symptoms in rare blood cancer | ||
| 13.12. | Medtronic's latest ingestible PillCam completes first patient GI procedure | ||
| 13.12. | AbbVie buys Roche spinout Nimble Therapeutics for $200M | ||
| 13.12. | BeiGene inks $150M deal to follow cancer combo trail blazed by Amgen and Ideaya |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
